VENUSREM - Venus Remedies Ltd. Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

VENUSREM

61/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹1006.75+38.95(+4.02%)

Market Open as of May 8, 2026, 15:30 IST

Select time range

Pros

Momentum: Stock price has a strong positive momentum. Stock is up 4.8% in last 30 days.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Balance Sheet: Strong Balance Sheet.

Past Returns: Outperforming stock! In past three years, the stock has provided 70.2% return compared to 9.8% by NIFTY 50.

Profitability: Recent profitability of 11% is a good sign.

Cons

Dividend: Stock hasn't been paying any dividend.

Valuation
Market Cap	1.35 kCr
Price/Earnings (Trailing)	17.63
Price/Sales (Trailing)	1.87
EV/EBITDA	10.57
Price/Free Cashflow	7.94
MarketCap/EBT	12.99
Enterprise Value	1.35 kCr

Fundamentals
Revenue (TTM)	719.56 Cr
Rev. Growth (Yr)	2.2%
Earnings (TTM)	76.31 Cr
Earnings Growth (Yr)	30.5%

Profitability
Operating Margin	14%
EBT Margin	14%
Return on Equity	12.84%
Return on Assets	9.93%
Free Cashflow Yield	12.59%

Growth & Returns
Price Change 1W	4.1%
Price Change 1M	4.8%
Price Change 6M	125.6%
Price Change 1Y	233.5%
3Y Cumulative Return	70.2%
5Y Cumulative Return	24.8%
7Y Cumulative Return	64.4%
10Y Cumulative Return	27.8%

Balance Sheet
Total Assets	768.1 Cr
Total Liabilities	173.79 Cr
Shareholder Equity	594.31 Cr
Current Assets	485.7 Cr
Current Liabilities	143.05 Cr
Net PPE	138.05 Cr
Inventory	106.67 Cr
Goodwill	0.00

Technical Indicators
RSI (14d)	45.75
RSI (5d)	63.33
RSI (21d)	57.98
MACD Signal	Sell
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Buy
RSI Signal	Hold
RSI5 Signal	Hold
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Shareholder Name	Holding %
Sunev Pharma Solutions Private Limited	17.21%
Pawan Chaudhary	12.82%
Manu Chaudhary	11.73%
Tikri Partners LLP	1.97%
K.B.Shekar	1.42%
Rajni Tarun Jain	1.42%
Nisarg Ajaykumar Vakharia	1.05%
Ashutosh Jain	0%
Akshansh Chaudhary	0%
Peeyush Jain	0%

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	7.8%	648	601	556	599	548	341
Other Income	81.8%	21	12	10	8.31	20	5.31
Total Income	9.2%	669	613	566	607	568	347
Cost of Materials	1.5%	349	344	318	382	348	168
Purchases of stock-in-trade	100%	25	13	5.16	0	0	0
Employee Expense	11.3%	80	72	61	52	46	46
Finance costs	-2.2%	0.07	0.09	0.29	0.48	13	13
Depreciation and Amortization	-12%	23	26	32	34	35	32
Other expenses	7.8%	125	116	103	99	108	80
Total Expenses	6.9%	607	568	528	571	543	346
Profit Before exceptional items and Tax	38.6%	62	45	38	36	25	0.78
Exceptional items before tax	-	9.91	0	0	0	23	-8.81
Total profit before tax	61.4%	72	45	38	36	49	-8.03
Current tax	63.6%	19	12	0	0	0	0
Deferred tax	24.6%	4.65	3.93	11	-4.32	-13.21	1.96
Total tax	53.3%	24	16	11	-4.32	-13.21	1.96
Total profit (loss) for period	63%	45	28	27	41	62	-10
Other comp. income net of taxes	26.3%	-0.68	-1.28	-6.71	-0.56	-0.1	-0.47
Total Comprehensive Income	69.2%	45	27	20	40	62	-10.47
Earnings Per Share, Basic	62%	33.9	21.31	19.88	30.86	50.04	-8.101
Earnings Per Share, Diluted	62%	33.9	21.31	19.88	30.86	50.04	-8.101

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	-6.8%	180	193	132	195	177	167
Other Income	114.1%	2.52	1.71	8.69	6.76	2.03	11
Total Income	-5.7%	183	194	141	202	179	178
Cost of Materials	-12.3%	94	107	71	104	98	77
Purchases of stock-in-trade	4.7%	1.9	1.86	2.27	2.13	5.5	8.38
Employee Expense	-9.1%	21	23	20	21	20	22
Finance costs	0%	0.01	0.01	0.01	0.01	0.01	0.02
Depreciation and Amortization	7.5%	6.56	6.17	6.18	4.71	5.41	6.4
Other expenses	12.9%	36	32	27	42	29	33
Total Expenses	-11.4%	149	168	128	171	164	169
Profit Before exceptional items and Tax	28%	33	26	13	31	15	9.07
Exceptional items before tax	-	0	0	0	0	9.91	0
Total profit before tax	28%	33	26	13	31	25	9.07
Current tax	33%	8.25	6.45	3.7	5.28	7.38	3.73
Deferred tax	-24.8%	-0.36	-0.09	-0.69	1.83	-2.1	1.83
Total tax	28.5%	7.89	6.36	3.01	7.11	5.28	5.56
Total profit (loss) for period	31.6%	26	20	9.6	21	20	3.52
Other comp. income net of taxes	246.2%	1.9	1.26	2.36	-0.81	-1.75	1.83
Total Comprehensive Income	30%	27	21	12	20	18	5.35
Earnings Per Share, Basic	29%	19.14	15.06	7.18	15.71	14.66	2.63
Earnings Per Share, Diluted	-14.6%	19.14	22.24	7.18	15.71	14.66	2.63

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	11.1%	639	575	538	575	515	341
Revenue From Operations	-	-	-	-	-	-	-
Other Income	100%	21	11	10	8.43	18	5.31
Other Income	-	-	-	-	-	-	-
Total Income	12.5%	660	587	548	584	532	347
Total Income	-	-	-	-	-	-	-
Cost of Materials	1.5%	349	344	317	373	344	168
Cost of Materials	-	-	-	-	-	-	-
Purchases of stock-in-trade	100%	25	13	5.16	0	0	0
Employee Expense	16.4%	72	62	52	44	36	46
Employee Expense	-	-	-	-	-	-	-
Finance costs	-	0	0	0	0	13	13
Finance costs	-	-	-	-	-	-	-
Depreciation and Amortization	-16%	22	26	31	33	34	32
Depreciation and Amortization	-	-	-	-	-	-	-
Other expenses	22.2%	122	100	87	87	95	80
Other expenses	-	-	-	-	-	-	-
Total Expenses	9.5%	591	540	508	539	515	346
Total Expenses	-	-	-	-	-	-	-
Profit Before exceptional items and Tax	47.8%	69	47	40	45	18	0.78
Profit Before exceptional items and Tax	-	-	-	-	-	-	-
Exceptional items before tax	-	9.91	0	0	0	23	-8.81
Total profit before tax	69.6%	79	47	40	45	41	-8.03
Total profit before tax	-	-	-	-	-	-	-
Current tax	63.6%	19	12	0	0	0	0
Deferred tax	24.6%	4.65	3.93	11	-4.32	-13.21	1.96
Deferred tax	-	-	-	-	-	-	-
Total tax	53.3%	24	16	11	-4.32	-13.21	1.96
Total tax	-	-	-	-	-	-	-
Total profit (loss) for period	79.3%	53	30	29	49	54	-10
Total profit (loss) for period	-	-	-	-	-	-	-
Other comp. income net of taxes	-49%	-0.43	0.04	-0.36	0.24	-0.1	-0.47
Total Comprehensive Income	70%	52	31	29	49	54	-10.47
Total Comprehensive Income	-	-	-	-	-	-	-
Earnings Per Share, Basic	75.6%	39.32	22.82	24.67	37.12	43.97	-8.1
Earnings Per Share, Basic	-	-	-	-	-	-	-
Earnings Per Share, Diluted	75.6%	39.32	22.82	21.67	37.12	43.97	-8.1
Earnings Per Share, Diluted	-	-	-	-	-	-	-

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	-63.2%	22	58	31	49	4.53	21
Current investments	131.3%	193	84	56	19	3.07	20
Total current financial assets	20.3%	333	277	203	168	147	152
Inventories	7.1%	107	100	120	122	159	120
Current tax assets	-16.6%	9.34	11	15	30	30	30
Total current assets	7.5%	486	452	391	360	374	323
Property, plant and equipment	10.5%	138	125	127	133	130	137
Capital work-in-progress	32%	34	26	23	21	26	26
Investment property	-	0	0	0.02	-	-	0
Non-current investments	-	0.02	0	8.12	0	0	0
Total non-current financial assets	21.9%	6.73	5.7	9.05	5.25	3.65	2.82
Total non-current assets	6.8%	282	264	269	267	267	278
Total assets	7.3%	768	716	660	627	640	601
Borrowings, non-current	-	0	0	39	39	39	39
Total non-current financial liabilities	-	12	0	39	39	39	39
Provisions, non-current	15.3%	3.19	2.9	11	10	8.98	8.85
Total non-current liabilities	76.5%	31	18	65	60	60	58
Borrowings, current	-50.7%	1.34	1.69	2.23	2.65	3.06	3.61
Total current financial liabilities	10.5%	138	125	99	77	101	81
Provisions, current	-75.2%	2.26	6.08	1.19	1.05	8.13	0.89
Total current liabilities	5.2%	143	136	101	79	110	83
Total liabilities	12.3%	174	155	166	139	169	141
Equity share capital	0%	13	13	13	13	13	13
Total equity	5.9%	594	561	494	488	471	460
Total equity and liabilities	7.3%	768	716	660	627	640	601

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	-63%	21	55	31	49	4.01	20
Current investments	131.3%	193	84	56	19	3.07	20
Total current financial assets	31.8%	345	262	203	176	160	159
Inventories	7.1%	107	100	120	118	134	114
Current tax assets	-16.6%	9.34	11	15	30	30	30
Total current assets	14%	497	436	391	361	359	318
Property, plant and equipment	10.9%	123	111	127	119	115	122
Capital work-in-progress	32%	34	26	23	21	26	26
Investment property	-	0	0	0.02	0	0	0
Non-current investments	-	0.16	0	0.02	0.16	0.14	0.14
Total non-current financial assets	3%	35	34	9.07	34	32	32
Total non-current assets	6.2%	294	277	269	280	280	291
Total assets	11.1%	792	713	660	641	638	609
Borrowings, non-current	-	0	0	39	39	39	39
Total non-current financial liabilities	-	12	0	39	39	39	39
Provisions, non-current	15.3%	3.19	2.9	11	10	8.99	8.85
Total non-current liabilities	76.5%	31	18	65	60	60	58
Borrowings, current	-	0	0	2.22	0	0	0
Total current financial liabilities	40.9%	132	94	99	71	82	71
Provisions, current	-75.6%	2.24	6.08	1.19	1.05	8.13	0.89
Total current liabilities	29.8%	136	105	101	73	91	73
Total liabilities	35%	167	124	166	133	151	131
Equity share capital	0%	13	13	13	13	13	13
Total equity	5.9%	625	590	494	509	488	478
Total equity and liabilities	11.1%	792	713	660	641	638	609

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Change in inventories	754.5%	19	-1.75	0	0	-	-
Depreciation	-12%	23	26	32	34	-	-
Unrealised forex losses/gains	-41.4%	-2.11	-1.2	-7.29	-6.31	-	-
Adjustments for interest income	-	0	0	1.78	0.64	-	-
Net Cashflows from Operations	89.3%	107	57	37	41	-	-
Interest paid	-17.6%	-0.07	0.09	0	0	-	-
Interest received	-7.4%	-4.54	-4.16	0	0	-	-
Income taxes paid (refund)	21.4%	18	15	0	0	-	-
Other inflows (outflows) of cash	-	2.11	0	0	0	-	-
Net Cashflows From Operating Activities	136.1%	86	37	37	41	-	-
Proceeds from sales of PPE	-53.8%	0.2	0.48	0.07	0.42	-	-
Purchase of property, plant and equipment	3.7%	9.63	9.32	7.82	14	-	-
Purchase of intangible assets	132.8%	8.45	4.2	0	0	-	-
Proceeds from sales of long-term assets	-470.4%	0	1.27	0	0	-	-
Cash receipts from repayment of advances and loans made to other parties	-	0	0	0	0.1	-	-
Interest received	11.7%	4.54	4.17	1.9	0.82	-	-
Other inflows (outflows) of cash	3.3%	0.41	0.39	-24.98	-4.25	-	-
Net Cashflows From Investing Activities	-840.9%	-76.25	-7.21	-50.83	-16.63	-	-
Proceeds from borrowings	49.7%	0	-0.99	-0.45	0	-	-
Repayments of borrowings	-	0.95	0	0	9.02	-	-
Interest paid	-2.2%	0.07	0.09	0.12	0.18	-	-
Other inflows (outflows) of cash	-	0	0	0	-0.28	-	-
Net Cashflows from Financing Activities	2.9%	-1.02	-1.08	-0.57	-9.48	-	-
Effect of exchange rate on cash eq.	28%	-0.62	-1.25	-7.27	-0.52	-	-
Net change in cash and cash eq.	-72%	8.56	28	-22.05	14	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Change in inventories	407.1%	17	-4.21	-23.84	-24.22	-	-
Depreciation	-16%	22	26	31	33	-	-
Unrealised forex losses/gains	-48.8%	-2.11	-1.09	-7.32	-6.72	-	-
Adjustments for interest income	-	0	0	1.9	0.77	-	-
Net Cashflows from Operations	88.9%	103	55	28	41	-	-
Interest received	-7.4%	-4.54	-4.16	0	0	-	-
Income taxes paid (refund)	21.4%	18	15	0	0	-	-
Other inflows (outflows) of cash	-	2.11	0	0	0	-	-
Net Cashflows From Operating Activities	141.2%	83	35	28	41	-	-
Proceeds from sales of PPE	-53.8%	0.2	0.48	0.07	0.42	-	-
Purchase of property, plant and equipment	6.6%	9.58	9.05	7.8	14	-	-
Purchase of intangible assets	132.8%	8.45	4.2	0	0	-	-
Proceeds from sales of long-term assets	-470.4%	0	1.27	0	0	-	-
Cash receipts from repayment of advances and loans made to other parties	-	0	0	0	0.1	-	-
Interest received	12%	4.54	4.16	1.9	0.77	-	-
Other inflows (outflows) of cash	3.3%	0.41	0.39	-24.98	-4.25	-	-
Net Cashflows From Investing Activities	-871.1%	-76.2	-6.95	-50.81	-16.65	-	-
Proceeds from borrowings	-	0	0	0	-8.84	-	-
Other inflows (outflows) of cash	-	0	0	0	-0.28	-	-
Net Cashflows from Financing Activities	-	0	0	0	-9.12	-	-
Net change in cash and cash eq.	-78.1%	6.9	28	-22.76	15	-	-

Capital Structure & Leverage
Debt Ratio	0.00
Debt/Equity	0.00
Interest Coverage	2.59 K

Dividend & Shareholder Returns
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Investor Care
Shares Dilution (1Y)	0.00%
Earnings/Share (TTM)	57.09

Financial Health
Current Ratio	3.4
Debt/Equity	0.00

VENUSREM - Venus Remedies Ltd. Share Price

VENUSREM

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

VENUSREM

VENUSREM - Venus Remedies Ltd. Share Price

VENUSREM

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

VENUSREM

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Venus Remedies Ltd. do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Venus Remedies Ltd. do?

Important Disclosure & Data Context